Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: FEBS J. 2017 Jul 25;285(2):233–243. doi: 10.1111/febs.14154

Figure 4. TPC Pharmacology.

Figure 4

A) Predicted binding site for DHP (red) Cav blockers based on sequence homology with Cavs overlaid onto the AtTPC1 structure bound to non-DHP molecule trans-NED-19 (PDB 5DQQ; ref. [20]). B) Molecular structure of representative pharmacophores that block TPC channels.